Northstar Financial Companies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.52M Buy
2,098
+273
+15% +$279K 1.7% 17
2026
Q1
$1.68M Buy
1,825
+345
+23% +$350K 1.33% 21
2025
Q4
$1.59M Buy
1,480
+640
+76% +$612K 1.27% 21
2025
Q3
$641K Buy
840
+502
+149% +$374K 0.59% 41
2025
Q2
$263K Sell
338
-778
-70% -$605K 0.27% 85
2025
Q1
$922K Buy
1,116
+35
+3% +$29.1K 1% 23
2024
Q4
$835K Buy
+1,081
New +$895K 0.79% 27

Other funds holding LLY

Northstar Financial Companies's LLY Position: Q2 2026 in Review

Northstar Financial Companies increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $279K and bringing the position to 2,098 shares worth $2.52M. The position accounts for 1.7% of the portfolio, ranked #17.

Northstar Financial Companies first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,851 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Northstar Financial Companies held 2,098 shares of Eli Lilly worth $2.52M as of Q2 2026.
  • Northstar Financial Companies bought 273 Eli Lilly shares in Q2 2026, an estimated $279K.
  • Eli Lilly made up 1.7% of Northstar Financial Companies's portfolio in Q2 2026, its #17 holding.
  • Northstar Financial Companies first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,851 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Northstar Financial Companies's 13F filing for Q2 2026, filed 6 Aug 2026.